Cargando…

Conservative treatment of borderline ovarian tumors: a retrospective study

Borderline ovarian tumors (BOTs) are a group of tumors with histological aspects and intermediate biological evolution between benign and malignant tumors, characterized by epithelial proliferation, lack of stromal invasion and nuclear atypia. BOTs account for approximately 10–15% of epithelial ovar...

Descripción completa

Detalles Bibliográficos
Autores principales: Văduva, Constantin-Cristian, Constantinescu, Carmen, Ţenovici, Mihaela, Boldeanu, Lidia, Istrate-Ofiţeru5, Anca-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520401/
https://www.ncbi.nlm.nih.gov/pubmed/37518870
http://dx.doi.org/10.47162/RJME.64.2.03
Descripción
Sumario:Borderline ovarian tumors (BOTs) are a group of tumors with histological aspects and intermediate biological evolution between benign and malignant tumors, characterized by epithelial proliferation, lack of stromal invasion and nuclear atypia. BOTs account for approximately 10–15% of epithelial ovarian carcinomas. The interest in fertility preservation is very important as most BOTs are diagnosed in patients less than 40 years of age. Since borderline tumors occur in young, fertile women, the therapeutic approach depends on both staging and the need to preserve ovarian function and fertility. Treatment of BOT is primarily surgical, but recently fertility-preserving surgery has become more important. If infertility persists, ovarian induction or in vitro fertilization (IVF) may be suggested in selected cases.